- Cikk címe: Influenced and independent? Network Analysis of 39 Months of Prescription Medication Ads in the Hungarian Medical Journals
- Szerzők: Brys Zoltán, Tímár György, Pluhár András, Horváth Gabriella
- Intézmények: Literatura Medica Network Science Section, University of Szeged, Institute of Informatics, COMFIT Ltd.
- Évfolyam: XIII. évfolyam
- Lapszám: 2014. / 5
- Hónap: június
- Oldal: 22-25
- Terjedelem: 4
- Rovat: MENEDZSMENT
- Alrovat: MENEDZSMENT KOMMUNIKÁCIÓ
Angol absztrakt:
Prescription medication ad in medical journals is an important element of drug marketing, which is aiming to influence physician prescription behavior. Prescription medication marketing is a complex, sensitive and controversial ethical and legal question. Using quantitative and network analysis we examined the market of the prescription medication ads in Hungarian medical journals.
XIII. évfolyam
2014. / 5. lapszám június
| Szerző | Intézmény |
|---|---|
| Szerző: Brys Zoltán | Intézmény: Literatura Medica Network Science Section |
| Szerző: Tímár György | Intézmény: University of Szeged |
| Szerző: Pluhár András | Intézmény: Institute of Informatics |
| Szerző: Horváth Gabriella | Intézmény: COMFIT Ltd. |
[1]Ladeira W, Dalmar M, Maehler AE, Araujo CF, (2011) Drug prescription practices in Brazil: a structural equa- tion model, International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5 Iss: 4, pp.262 – 278
[2]Al-Areefi MA, Hassali MA, Ibrahim MIBM (2012) A qua- litative study exploring medical representativesʼ views on current drug promotion techniques in Yemen, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing August 2012 vol. 12 no. 3 143-149
[3]Singh R (2008) Network Connectedness of Pharmaceutical Sales Rep (FLE)-Physician Dyad and Physician Prescription Behaviour: A Conceptual Model, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, June 2008; vol. 8, 3: pp. 257-268.
[4]FF Gönül, Carter FJ, (2012) Estimation of promotional strategies for newer vs older drugs based on physician prescribing data International Journal of Pharmaceutical and Healthcare Marketing, Vol. 6 Iss: 1, pp.39 – 54
[5]Kroes M, Chmielarz P, Chandler L, Bergler M, Smith B(2011) Beyond KOL management: communities of practice as a new perspective on pharmaceutical mar- ket penetration, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing February 2011 vol. 11 no. 1 71-83
[6]Borbas C, Morris N, McLaughlin B, Asinger R, Gobel F. (2000) The role of clinical opinion leaders in guideline implementation and quality improvement. Chest 2000 Aug;118(2 Suppl):24S-32S.
[7]Tanne JH (2010) Most leading US medical schools lack rules on ghostwriting BMJ 2010;340:c799
[8]Schneider N, Lückmann SL (2008) Pharmaceutical Industry Sponsored Medical Education, Zeitschrift für Allgemeinmedizin, 2008, vol. 84, no12, pp. 516-524
[9]Goodle F (2009) Doctors, patients, and the drug in- dustry, BMJ 2009;338:b463
[10]Roehr B (2012) GlaxoSmithKline is fined record $3bn in US. BMJ 2012;345:e4568 (Published 3 July 2012)
[11]Smith R (2005) Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies. PLoS Med 2(5): e138. doi:10.1371/journal.pmed.0020138
[12]MTI – Hungarian news agency (2012): Bírságolt az OGYI a magyar orvos thaiföldi halála után (downloaded at 2012 from : http://www.origo.hu/itthon/20110318-bir- sagolt-az-ogyi-a-magyar-orvos-thaifoldi-halala- utan.html )
[13]Raghavan UN, Albert R, Kumara S (2007) Near linear time algorithm to detect community structures in large- scale networks, Phys Rev E 76 036106.
[14]Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. (2011) Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 2011 Feb 1;27(3):431-2. doi: 10.1093/bioinformatics/btq675. Epub 2010 Dec 12.
[15]Newman MEJ (2005) Power laws, Pareto distributions and Zipfʼs law, Contemporary Physics, Vol. 46/5 (2005).
[16]Prajapati, Dureja H (2012) Product lifecycle manage- ment in pharmaceuticals, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing August 2012 vol. 12 no. 3 150-158
[17]Studdert MS, Mello MM. Brennan TA(2004) Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal Prosecution N Engl J Med 2004; 351:1891-1900